Every 424B that Welltower Inc. (WELL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow WELL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WELL filings page.
Welltower Inc. is registering for resale up to 261,753 shares of its $1.00 par value common stock held by two selling stockholders. These shares will be issued to the selling stockholders upon exchange of securities provided as consideration in a recent lease amendment relating to certain properties. Welltower will not receive any proceeds from subsequent sales; all proceeds go to the selling stockholders, who may sell through brokers, negotiated transactions, or other permitted methods. Welltower, a healthcare-focused REIT with over 2,500 seniors and wellness communities, had 720,744,765 shares of common stock outstanding as of July 24, 2026, and its stock trades on the NYSE under the symbol WELL, with a last reported price of $248.34 on July 27, 2026. The company highlights REIT-related ownership limits, including a 9.8% cap on ownership of its common stock or overall capital stock to protect REIT status.
Welltower Inc., a healthcare-focused REIT, has established a new at-the-market equity distribution program to offer and sell shares of its common stock with an aggregate offering price of up to $7,500,000,000. Sales may be made from time to time through a large syndicate of banks acting as sales agents and, in some cases, as forward sellers, as well as through related forward purchasers.
The company may enter into forward sale agreements under which a forward purchaser (or affiliate) borrows and sells shares now, with Welltower later choosing physical, cash or net share settlement. Welltower will not receive proceeds from the initial sale of borrowed shares, but expects to receive cash upon physical settlement at the applicable forward sale price, adjusted daily for interest and expected dividends. Cash or net share settlement could instead create cash payment obligations or share deliveries by Welltower, and physical or net share settlement would dilute earnings per share and return on equity.
Net proceeds from direct issuances through sales agents and, if any, from physical settlement of forward sales are expected to be used for general corporate purposes, including debt repayment and funding investments in healthcare and seniors housing properties, with temporary investment in short-term, investment grade instruments. Sales agents and forward sellers earn up to 1.50% of gross sales prices as commissions. Welltower’s common stock trades on the NYSE under the symbol WELL and last traded at $248.34 per share on July 27, 2026. The company remains subject to a 9.8% ownership cap in its governing documents to support REIT status.
Welltower Inc. through its subsidiary Welltower OP LLC is offering C$750,000,000 of 3.850% notes due 2031 and C$400,000,000 of 4.150% notes due 2033, with a full unconditional senior unsecured guarantee by Welltower Inc.
The offering price is approximately C$1,149,719,000 before expenses, expected net proceeds are approximately C$1.142 billion, and settlement is expected on or about July 13, 2026. Net proceeds are intended for general corporate purposes, including repayment of debt and funding investments in healthcare and seniors housing.
Welltower OP LLC is offering two series of Canadian dollar notes, each fully and unconditionally guaranteed by Welltower Inc. The prospectus supplement dated July 6, 2026 describes semiannual interest, CAD payments, optional and tax-triggered redemptions, and senior unsecured ranking. Proceeds are intended for general corporate purposes, including repayment of debt and funding healthcare and seniors housing investments. The notes will be issued in book-entry form through CDS, may be held through Clearstream or Euroclear, and carry covenants limiting liens (40%) and indebtedness (60%) and requiring minimum Interest Coverage and Total Unencumbered Assets thresholds.
Welltower Inc. registered 138,740 shares of common stock for resale by a selling stockholder. The shares will be issued to the selling stockholder upon exchange of securities issued as consideration in a recent property acquisition. The company will not receive any proceeds from sales of these shares. The prospectus supplement names Amica Unionville Partnership as the selling stockholder and states the shares may be sold from time to time in one or more transactions, including block trades, broker-dealer transactions or Rule 144 sales. The supplement quotes a NYSE last-sale price of $214.23 per share as of April 28, 2026 and discloses 705,914,450 shares outstanding as of April 24, 2026.
Welltower Inc. registers 176,172 shares of common stock to be issuable from time to time in exchange for Class A common units of Welltower OP LLC, pursuant to contractual registration obligations. The registration is to satisfy those contractual rights; issuance occurs only if holders present Class A Units for redemption.
The company will receive no cash proceeds from any issuance and instead will acquire Class A Units in exchange for delivered shares. The prospectus supplement cites a last reported NYSE sale price of $214.23 per share as of April 28, 2026. As of March 20, 2025, Welltower reported 648,417,266 shares outstanding.
Welltower Inc. registered up to 4,542,926 shares of common stock under a prospectus supplement for issuance, from time to time, in exchange for Class A common units of Welltower OP LLC tendered for redemption. Shares will be issued only if holders present Class A Units for redemption.
Welltower will receive no cash proceeds from these issuances; it will acquire Class A Units in exchange. The company waived the one‑year holding period for these specific Class A Units and agreed to deliver common stock upon redemption, waiving its right to pay cash. WELL trades on the NYSE under “WELL”; the last reported sale price was $182.61 per share on October 27, 2025.
The filing arises from a call contribution agreement dated October 16, 2025 related to a recent property acquisition, and includes customary plan of distribution provisions. Ownership limits in the by‑laws cap any holder at 9.8% of outstanding common stock or total capital stock.
Welltower Inc. (WELL) launched an at-the-market offering of up to $7,500,000,000 of common stock under a new equity distribution agreement with multiple banks acting as sales agents and forward sellers, with optional forward sale agreements with affiliated forward purchasers. Sales may be made on the NYSE or other methods permitted by law, subject to “up to” limits and availability of authorized, unissued shares.
The company will pay sales agents a fee not to exceed 1.50% of the gross sales price per share. In forward setups, a forward seller will sell borrowed shares; Welltower will not receive proceeds from those borrowed share sales and expects to physically settle forward agreements to receive per‑share cash proceeds at the applicable forward sale price. The company may elect cash or net share settlement, which could result in cash payments or share delivery. The prior March 2025 equity distribution agreement was terminated; $5,259,398,390 of common stock had been sold under it. WELL last traded at $182.61 per share on October 27, 2025.